The novel Bruton tyrosine kinase inhibitor branebrutinib abrogates lipopolysaccharide/galactosamine-induced hepatic injury via limiting inflammation and oxidative stress

Biomedicine & Pharmacotherapy | 2025

DOI: https://doi.org/10.1016/j.biopha.2025.118462

Targeting amyloid β42 aggregation using a structurally defined graphene quantum dot model: A combined molecular and biological investigation

International Journal of Biological Macromolecules | 2025

DOI: https://doi.org/10.1016/j.ijbiomac.2025.146205

The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen-Resistant Breast Cancer Cells In Vitro

International Journal of Genomics | 2018

DOI: https://doi.org/10.1155/2018/7628734